References
Afzali B, Al-Khoury S, Shah N, Mikhail A, Covic A, Goldsmith D (2006) Anemia after renal transplantation. Am J Kidney Dis 48:519–536
Karalliedde J, Viberti G (2006) Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes. J Hum Hypertens 20:239–253
Gartenmann AC, Fossali E, von Vigier RO, Simonetti GD, Schmidtko J, Edefonti A, Bianchetti MG (2003) Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. Kidney Int 64:1450–1454
Yim HE, Kim MK, Bae IS, Kim JH, Choi BM, Yoo KH, Hong YS, Lee JW (2006) AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney. Pediatr Nephrol 21:1377–1388
Rossing K, Schjoedt KJ, Jensen BR, Boomsma F, Parving HH (2005) Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 68:1190–1198
Ersoy A, Kahvecioglu S, Ersoy C, Cift A, Dilek K (2005) Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis. Transplant Proc 37:2148–2150
Sackey AH (1998) Anaemia after enalapril in a child with nephrotic syndrome. Lancet 352:285–286
Author information
Authors and Affiliations
Corresponding author
Additional information
Giacomo D. Simonetti is currently supported by a scholarship of the Ettore e Valeria Rossi Foundation.
Rights and permissions
About this article
Cite this article
Simonetti, G.D., Bianchetti, M.G., Konrad, M. et al. Severe anemia caused by the angiotensin receptor blocker irbesartan after renal transplantation. Pediatr Nephrol 22, 756–757 (2007). https://doi.org/10.1007/s00467-006-0400-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0400-3